High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant. [electronic resource]
Producer: 19930524Description: 704-11 p. digitalISSN:- 0732-183X
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Marrow Transplantation -- adverse effects
- Combined Modality Therapy
- Etoposide -- administration & dosage
- Female
- Hodgkin Disease -- drug therapy
- Humans
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.